Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01673373 · ClinicalTrials.gov registry record · NA
Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension
A NA study, sponsored by Atrium Medical Corporation.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT01673373: Completed NA study, sponsored by Atrium Medical Corporation.
NCT01673373 is a NA study that has completed, run by Atrium Medical Corporation. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01673373, a NA study, has completed, sponsored by Atrium Medical Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this trial is to test how well the iCAST™ RX Stent works in patients diagnosed with atherosclerotic renal artery stenosis and whether or not increased blood flow by the stent will help to control blood pressure.
Primary Outcome
Primary patency rate at 9 months was defined as continuous patency without the occurrence of a total occlusion of the original lesion, without a re-intervention to treat a partial or total occlusion of the stented segment, or bypass of the stented segment due to clinically-driven restenosis or occlusion.
Interventions
- DEVICE iCAST™ Rx Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2012-10-23 |
| Est. Completion | 2020-10-26 |
| Phase | NA |
What the finished NCT01673373 record still lists
NCT01673373 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which iCAST™ Rx Stent System is the first listed.
NCT01673373 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01673373 about?
NCT01673373 is a clinical study titled "Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension". The purpose of this trial is to test how well the iCAST™ RX Stent works in patients diagnosed with atherosclerotic renal artery stenosis and whether or not increased blood flow by the stent will help to control blood pressure.
What is the current status of trial NCT01673373?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2012-10-23. Estimated completion is 2020-10-26.
What interventions are being tested in trial NCT01673373?
The interventions under investigation include: iCAST™ Rx Stent System (DEVICE).
Who is sponsoring clinical trial NCT01673373?
This trial is sponsored by Atrium Medical Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01673373's enrollment target sits among peer trials
68 1133rd of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI